The High Court of Uganda has rejected a challenge from Mathias Magoola, owner of Dei Biopharma Ltd and DEI Industries International Ltd, to prevent an independent audit of the company’s loan facilities. The loans were obtained from Equity Bank Uganda and Equity Bank Kenya. Dei Biopharma, a pharmaceutical manufacturer, has been a recipient of significant government funding. The court’s decision clears the way for the audit to proceed, investigating the financial dealings of the company. This development follows scrutiny over how the billions of shillings in public funds were utilized. The audit aims to provide transparency and accountability regarding the loan facilities and government investment within Dei Biopharma. Further details regarding the scope and timeline of the audit have not yet been released.